आपल्याला अधिक आत्मविश्वासाने गुंतवणूक करण्यात मदत करण्यासाठी तपशीलवार आयपीओ पुनरावलोकने, क्षेत्र विश्लेषण आणि शैक्षणिक मार्गदर्शक एक्सप्लोर करा.
Check the latest upcoming IPOs in India, including SRIT India, Shah Investor's Home, Vishal Nirmiti, Nityas Gems and 16 SME IPOs. Get price bands, issue sizes, dates and GMP updates.
Lumino Industries IPO opened for subscription on August 27, 2026, with strong grey-market interest. The ₹700 crore mainboard IPO is priced at ₹78–₹82 per share and includes a ₹500 crore fresh issue plus ₹200 crore OFS. The power cable and EPC company reported FY2026 revenue of ₹2,041.07 crore and PAT of ₹160 crore, while its order book stood at ₹3,149.8 crore. With GMP indicating around 61% potential listing gains, investors are watching opening-day demand, debt reduction and future power-infrastructure growth.
Kwick Forensic Solutions IPO opened on August 27, 2026, with a strong grey-market buzz. The ₹50.77 crore BSE SME issue is priced at ₹85–₹90 per share and includes a ₹41.05 crore fresh issue plus ₹9.72 crore OFS. The forensic technology company reported FY2026 revenue of ₹105.80 crore and PAT of ₹13.51 crore. Around ₹31.42 crore of IPO proceeds will fund working-capital requirements. With GMP indicating about 71% premium before bidding began, investors are watching subscription demand, government-sector opportunities and the sustainability of the company's rapid recent growth.
Sumax Engineering IPO gained strong momentum on August 27, 2026, with overall subscription reaching about 8.91 times in the latest available update. Retail demand led the issue at 17.15x, while NII subscription stood at 5.13x. The ₹53.40 crore NSE SME IPO is priced at ₹95–₹101 and closes on August 28. FY2026 revenue stood at ₹148.34 crore with PAT of ₹12.76 crore. Fresh proceeds will primarily support two proposed manufacturing facilities and working-capital requirements.
Hy-Tech Engineers IPO entered its final day on August 27, 2026, with exceptional investor demand. The ₹135.73 crore mainboard IPO, priced at ₹50–₹53 per share, was subscribed over 50 times in the latest update. Grey market sentiment has strengthened significantly, with GMP indicating an estimated 83% premium over the issue price. The engineering company plans to use IPO proceeds for working capital, capital expenditure and general corporate purposes. Investors are now focused on final subscription figures, allotment and the September listing.
Symbiotec Pharmalab IPO entered its final bidding day on August 27, 2026, with strong investor participation. The ₹1,757 crore mainboard IPO, priced at ₹938–₹988 per share, was subscribed around 5.63 times as of 10:03 AM, led by NII and retail investors. The latest reported GMP stands near ₹285, indicating an estimated 29% premium over the upper issue price. The pharmaceutical and biotechnology company reported FY2026 revenue of ₹869.15 crore and PAT of ₹109.90 crore. With only ₹150 crore of the IPO coming through fresh shares and ₹1,607 crore through OFS, investors will be watching final subscription, institutional demand, debt reduction and post-listing growth.
Skyways Air Services IPO entered its final bidding day on August 27, 2026, with strong investor demand. The ₹582.80 crore mainboard IPO, priced at ₹131–₹138 per share, was subscribed around 5.08 times in the latest available update, led by retail and NII investors. Grey-market sentiment has also strengthened, with the latest reported GMP indicating around 31% potential listing premium. The integrated logistics company plans to use fresh IPO proceeds mainly for debt repayment and working capital. Investors will now be watching the final subscription numbers, QIB participation and the September 1 listing.
Sumax Engineering IPO entered its second bidding day on August 26, 2026. The ₹53.40 crore NSE SME issue is priced at ₹95–₹101 per share and includes a ₹43.34 crore fresh issue and ₹10.06 crore OFS. The automotive-products manufacturer reported FY2026 total income of ₹148.34 crore and PAT of ₹12.76 crore. With fresh capital planned for two new manufacturing units and working-capital requirements, investors will be watching capacity expansion, margins and execution as the IPO moves toward its August 28 closing date.
Symbiotec Pharmalab IPO entered Day 3 on August 26, 2026, after receiving healthy investor demand during the first two days. The ₹1,757 crore mainboard IPO is priced at ₹938–₹988 per share and includes a ₹150 crore fresh issue with a ₹1,607 crore OFS. The pharmaceutical company manufactures APIs, nutritional ingredients and specialty products, with more than two-thirds of revenue coming from international markets. The IPO had reached 1.85x subscription on Day 2, while the latest reported GMP indicated around 34% potential upside. Investors are watching export growth, product concentration, margins and the planned reduction in borrowings.
Hy-Tech Engineers IPO is seeing strong investor interest on August 26, 2026. The ₹135.73 crore mainboard issue, priced at ₹50–₹53 per share, combines a ₹60 crore fresh issue with a ₹75.73 crore OFS. The company manufactures hydraulic fittings with a portfolio of more than 11,000 SKUs and serves industries including construction equipment, automotive, agriculture, railways and defence. FY2026 revenue rose to ₹189.40 crore while PAT reached ₹22.59 crore. With subscription crossing 20 times in the latest Day 3 update and grey-market sentiment remaining strong, investors are closely watching demand, valuation and the company's planned manufacturing expansion.
